Merck Beats Back Whistleblower's FCA Claims Over Integrilin
A California federal judge on Monday tossed a whistleblower's False Claims Act allegations against Merck and Co. Inc. of off-label promotion of Integrilin and kickbacks, ruling they were substantially similar to...To view the full article, register now.
Already a subscriber? Click here to view full article